Free Trial
NYSEAMERICAN:CCEL

Cryo-Cell International (CCEL) Stock Price, News & Analysis

Cryo-Cell International logo
$5.05 -0.30 (-5.61%)
Closing price 04:10 PM Eastern
Extended Trading
$5.00 -0.04 (-0.89%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Cryo-Cell International Stock (NYSEAMERICAN:CCEL)

Advanced

Key Stats

Today's Range
$5.00
▼
$5.35
50-Day Range
$3.53
▼
$5.35
52-Week Range
$2.72
▼
$5.45
Volume
6,522 shs
Average Volume
15,922 shs
Market Capitalization
$40.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cryo-Cell International, Inc. is a biotechnology and healthcare services company that provides stem cell collection, processing and long-term cryogenic storage. The company primarily focuses on preserving umbilical cord blood and cord tissue, which contain stem cells that may be used in certain medical treatments and regenerative medicine applications.

Its services are marketed primarily to expectant parents and families through private biological material banking programs. Cryo-Cell provides collection kits, coordination with healthcare professionals, laboratory processing and secure storage services. The company has also offered preservation services for menstrual stem cells through its C’elle program.

Founded in 1989, Cryo-Cell International is headquartered in Oldsmar, Florida. The company serves customers in the United States and has pursued international business through strategic relationships, affiliates and distribution arrangements. Its operations are centered on maintaining laboratory and storage capabilities for biological specimens over extended periods.

AI Generated. May Contain Errors.

Receive CCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CCEL Stock News Headlines

$0. Later: $29.97.
Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that link expires, it returns to its usual price of $29.97. The content stays the same - plain-English lessons and a handful of proven techniques - only the price changes. Waiting means paying for something you could have gotten for free.tc pixel
See More Headlines

CCEL Stock Analysis - Frequently Asked Questions

Cryo-Cell International's stock was trading at $3.44 at the start of the year. Since then, CCEL shares have increased by 46.8% and is now trading at $5.05.

Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) announced its earnings results on Friday, October, 9th. The company reported $0.16 earnings per share (EPS) for the quarter. The business had revenue of $7.82 million for the quarter.

Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cryo-Cell International investors own include Advanced Micro Devices (AMD), Walt Disney (DIS), GE Aerospace (GE), Jumia Technologies (JMIA), Netflix (NFLX), NVIDIA (NVDA) and Vertex Pharmaceuticals (VRTX).

Company Calendar

Last Earnings
10/09/2026
Today
11/03/2026
Fiscal Year End
11/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NYSEAMERICAN:CCEL
CIK
862692
Employees
76
Year Founded
1989

Profitability

EPS (Trailing Twelve Months)
($1.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.43 million
Net Margins
-6.25%
Pretax Margin
-6.13%
Return on Equity
N/A
Return on Assets
-3.17%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.86
Quick Ratio
0.82

Sales & Book Value

Annual Sales
$31.57 million
Price / Sales
1.29
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.03) per share
Price / Book
-2.49

Miscellaneous

Outstanding Shares
8,060,000
Free Float
4,843,000
Market Cap
$40.70 million
Optionable
Not Optionable
Beta
0.50

Social Links

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NYSEAMERICAN:CCEL) was last updated on 11/3/2026 by MarketBeat.com Staff.
From Our Partners